Obesity Abstracts

Newer anti-obesity medications (AOM) now offer the prospect of double-digit weight loss, and potentially clinical benefits beyond those from weight loss alone (e.g., diabetes remission, cardiovascular protection) all on a background of increasing prevalence and severity of obesity in most countries. Currently the analytical framework for evaluating efficacy has been anthropometric-centric but will need to develop as it has in other chronic disease areas to be more complication...